MarketPeel
Insider Trading Intelligence
JK

James R. Kasinger

CRSP
GENERAL COUNSEL AND SECRETARY · CRISPR THERAPEUTICS AG · CIK 0001708172
FILING MIX · LIFETIME50%/50%
BUYS
51
SELLS
52
TOTAL VALUE
$11.20M
COMPANIES
1
ACTIVE SINCE
Mar 2020
HOLDINGS NOW
17,000
AVG SELL PX
$106.59
TRADE KIND
SHOWING 103 / 103
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
19 backtested trades · 8 horizons · 20 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by James R. Kasinger, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d19+78.95%-5.96%-0.06%-5.90%-5.04%
14d19+78.95%-8.56%-0.61%-7.94%-10.38%
30d19+78.95%-13.13%+0.06%-13.20%-13.79%
60d19+78.95%-18.98%+1.75%-22.14%-19.73%
90d19+78.95%-18.76%+6.87%-25.62%-23.50%
180d19(4 pending)+66.67%-15.10%+9.85%-24.95%-46.82%
1y19(5 pending)+57.14%-26.06%+17.45%-43.51%-53.37%
2y19(11 pending)+100.00%-60.06%+16.72%-76.78%-81.66%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CRSP · 17,000 shares · as of May 29, 2026
025,24450,48775,731100,974202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 51 buys / 52 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CRSP
CRISPR THERAPEUTICS AG
PURCHASEGRANT
Stock grant
17,00017,000May 29, 2026Jun 2, 2026View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
3,182$46.78$148.9K94,308Mar 23, 2026Mar 24, 2026View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASEGRANT
Stock grant
25,00025,000Mar 20, 2026Mar 24, 2026View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
General Counsel and Secretary
6,25097,490Mar 20, 2026Mar 24, 2026View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
6,25012,000Mar 20, 2026Mar 24, 2026View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASEGRANT
Stock grant
38,49938,499Mar 20, 2026Mar 24, 2026View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
3,450$48.26$166.5K91,240Mar 16, 2026Mar 17, 2026View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
6,87520,625Mar 14, 2026Mar 17, 2026View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
General Counsel and Secretary
6,87594,690Mar 14, 2026Mar 17, 2026View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
2,800$52.80$147.8K87,815Mar 11, 2026Mar 12, 2026View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
5,5005,500Mar 10, 2026Mar 12, 2026View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
General Counsel and Secretary
5,50090,615Mar 10, 2026Mar 12, 2026View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
2,112$52.58$111.0K85,115Feb 19, 2026Feb 20, 2026View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
General Counsel and Secretary
3,82587,227Feb 18, 2026Feb 20, 2026View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
3,8250Feb 18, 2026Feb 20, 2026View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
1,076$66.60$71.7K83,402Oct 14, 2025Oct 15, 2025View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
2,1142,113Oct 13, 2025Oct 15, 2025View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
General Counsel and Secretary
2,11484,478Oct 13, 2025Oct 15, 2025View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASEGRANT
Stock grant
16,50016,500Oct 3, 2025Oct 3, 2025View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
3,185$41.23$131.3K81,729Mar 21, 2025Mar 24, 2025View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
General Counsel and Secretary
6,25084,914Mar 20, 2025Mar 24, 2025View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
6,25018,750Mar 20, 2025Mar 24, 2025View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASEGRANT
Stock grant
36,66636,666Mar 14, 2025Mar 18, 2025View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASEGRANT
Stock grant
27,50027,500Mar 14, 2025Mar 18, 2025View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
1,116$43.32$48.3K78,664Mar 12, 2025Mar 12, 2025View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
General Counsel and Secretary
2,25079,780Mar 11, 2025Mar 12, 2025View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
2,850$42.42$120.9K77,530Mar 11, 2025Mar 12, 2025View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
2,2500Mar 11, 2025Mar 12, 2025View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
5,50011,000Mar 10, 2025Mar 12, 2025View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
General Counsel and Secretary
5,50080,380Mar 10, 2025Mar 12, 2025View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
1,947$52.80$102.8K74,880Feb 19, 2025Feb 19, 2025View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
3,8253,825Feb 18, 2025Feb 19, 2025View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
General Counsel and Secretary
3,82576,827Feb 18, 2025Feb 19, 2025View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
9,595$53.85$516.7K73,002Feb 18, 2025Feb 19, 2025View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
General Counsel and Secretary
20,00082,597Feb 16, 2025Feb 19, 2025View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
20,0000Feb 16, 2025Feb 19, 2025View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASEGRANT
Stock grant
18,33318,333Oct 16, 2024Oct 18, 2024View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASEGRANT
Stock grant
30,00030,000Oct 16, 2024Oct 18, 2024View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
1,089$46.28$50.4K62,597Oct 14, 2024Oct 15, 2024View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
General Counsel and Secretary
2,11363,686Oct 13, 2024Oct 15, 2024View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
2,1134,227Oct 13, 2024Oct 15, 2024View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASEGRANT
Stock grant
25,00025,000Mar 20, 2024Mar 22, 2024View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASEGRANT
Stock grant
33,33333,333Mar 20, 2024Mar 22, 2024View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
1,146$74.44$85.3K61,174Mar 12, 2024Mar 12, 2024View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
2,2502,250Mar 11, 2024Mar 12, 2024View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
2,801$78.26$219.2K60,070Mar 11, 2024Mar 12, 2024View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
General Counsel and Secretary
2,25062,320Mar 11, 2024Mar 12, 2024View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
General Counsel and Secretary
5,50062,871Mar 10, 2024Mar 12, 2024View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
5,50016,500Mar 10, 2024Mar 12, 2024View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
1,913$79.67$152.4K57,371Feb 20, 2024Feb 21, 2024View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
General Counsel and Secretary
3,82559,284Feb 18, 2024Feb 21, 2024View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
3,8257,650Feb 18, 2024Feb 21, 2024View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASEGRANT
Stock grant
16,66716,667Oct 13, 2023Oct 17, 2023View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASEGRANT
Stock grant
6,3406,340Oct 13, 2023Oct 17, 2023View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
1,022$43.22$44.2K54,844Mar 13, 2023Mar 14, 2023View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
1,283$43.22$55.5K53,616Mar 13, 2023Mar 14, 2023View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
2,2504,500Mar 11, 2023Mar 14, 2023View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
General Counsel and Secretary
2,25055,866Mar 11, 2023Mar 14, 2023View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASEGRANT
Stock grant
22,00022,000Mar 10, 2023Mar 14, 2023View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
2,8330Mar 10, 2023Mar 14, 2023View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
General Counsel and Secretary
2,83354,899Mar 10, 2023Mar 14, 2023View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASEGRANT
Stock grant
40,00040,000Mar 10, 2023Mar 14, 2023View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
1,950$48.26$94.1K52,066Feb 21, 2023Feb 22, 2023View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
General Counsel and Secretary
3,82554,016Feb 18, 2023Feb 22, 2023View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
3,82511,475Feb 18, 2023Feb 22, 2023View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
3,234$52.26$169.0K50,191Dec 5, 2022Dec 6, 2022View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
General Counsel and Secretary
6,66753,425Dec 3, 2022Dec 6, 2022View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
6,6670Dec 3, 2022Dec 6, 2022View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASEGRANT
Stock grant
14,00014,000Oct 7, 2022Oct 12, 2022View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASEGRANT
Stock grant
20,00020,000Aug 16, 2022Aug 18, 2022View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
1,039$61.08$63.5K46,429Mar 14, 2022Mar 14, 2022View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
1,321$62.56$82.6K45,218Mar 11, 2022Mar 14, 2022View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
General Counsel and Secretary
2,25047,468Mar 11, 2022Mar 14, 2022View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
2,2506,750Mar 11, 2022Mar 14, 2022View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
General Counsel and Secretary
2,83446,539Mar 10, 2022Mar 14, 2022View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
2,8342,833Mar 10, 2022Mar 14, 2022View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASEGRANT
Stock grant
15,30015,300Feb 18, 2022Feb 22, 2022View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASEGRANT
Stock grant
34,20034,200Feb 18, 2022Feb 22, 2022View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
6,303$69.17$436.0K43,542Dec 6, 2021Dec 7, 2021View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
General Counsel and Secretary
13,33349,845Dec 3, 2021Dec 7, 2021View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
General Counsel and Secretary
13,3336,667Dec 3, 2021Dec 7, 2021View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
General Counsel and Secretary
7,342$13.62$100.0K36,512Dec 2, 2021Dec 3, 2021View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
7,34293,632Dec 2, 2021Dec 3, 2021View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASEGRANT
Stock grant
10,80010,800Oct 15, 2021Oct 18, 2021View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
4,741$117.86$558.8K29,170Sep 13, 2021Sep 14, 2021View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
General Counsel and Secretary
10,00033,911Sep 10, 2021Sep 14, 2021View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
10,0000Sep 10, 2021Sep 14, 2021View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASEGRANT
Stock grant
9,0009,000Mar 11, 2021Mar 12, 2021View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASEGRANT
Stock grant
25,36025,360Mar 11, 2021Mar 12, 2021View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
General Counsel and Secretary
2,83325,264Mar 10, 2021Mar 12, 2021View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
1,353$124.15$168.0K23,911Mar 10, 2021Mar 12, 2021View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
2,100$207.61$436.0K22,431Jan 19, 2021Jan 20, 2021View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
6,785$203.58$1.38M43,146Jan 19, 2021Jan 20, 2021View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
27,50012,500Jan 19, 2021Jan 20, 2021View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
1,800$206.05$370.9K24,531Jan 19, 2021Jan 20, 2021View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
General Counsel and Secretary
27,500$51.49$1.42M49,931Jan 19, 2021Jan 20, 2021View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
8,997$205.60$1.85M26,331Jan 19, 2021Jan 20, 2021View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
7,818$204.40$1.60M35,328Jan 19, 2021Jan 20, 2021View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
General Counsel and Secretary
22,026$13.62$300.0K22,415Dec 9, 2020Dec 10, 2020View →
CRSP
CRISPR THERAPEUTICS AG
SALE
General Counsel and Secretary
22,026100,974Dec 9, 2020Dec 10, 2020View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASEGRANT
Stock grant
11,66611,666Oct 5, 2020Oct 6, 2020View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASEGRANT
Stock grant
8,5008,500Mar 10, 2020Mar 12, 2020View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASEGRANT
Stock grant
35,00035,000Mar 10, 2020Mar 12, 2020View →
Other insiders · CRSP
Loading peer insiders…
About this filer
CIK 0001708172
ROLE
General Counsel and Secretary
PRIMARY
CRSP
COMPANIES
1
ACTIVE SINCE
Mar 2020
MARKETPEEL · /INSIDER/0001708172DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback